Moneycontrol
HomeNewsIndiaCOVID-19 | India’s daily vaccination crosses 1 crore doses for third time in last 11 days

COVID-19 | India’s daily vaccination crosses 1 crore doses for third time in last 11 days

With this, India’s cumulative COVID-19 vaccination coverage inched closer towards 70 crore with a total of 69,68,96,328 vaccine doses administered so far, the Union Ministry of Health and Family Welfare said on September 6.

September 06, 2021 / 21:54 IST
Story continues below Advertisement
A healthcare worker gives a dose of the COVISHIELD vaccine against the coronavirus disease (COVID-19), manufactured by Serum Institute of India, to a farmer in his field, during a door-to-door vaccination drive in Banaskantha district in the western state of Gujarat. (Representative image: Reuters)

India on September 6 administered more than one crore COVID-19 vaccine doses. A total of 1,05,76,911 vaccine doses have been administered today. This is the third time the country has achieved this feat in the past 11 days.

With this, India’s cumulative COVID-19 vaccination coverage inched closer towards 70 crore with a total of 69,68,96,328 vaccine doses administered so far, the Union Ministry of Health and Family Welfare said on September 6.

Story continues below Advertisement

Union Health Minister Mansukh Mandaviya tweeted: “September has started on a high note as India touches 1 crore COVID-19 vaccinations today. Under Prime Minister Narendra Modi’s leadership, the world’s largest vaccination drive is scaling massive heights.”

The first time India achieved this milestone was on August 27, with 1,00,64,032 doses of the coronavirus vaccine being administered.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show